Business
Montreal Heart Institute pilots Steriwave
Montreal Heart Institute pilots Steriwave.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n21 September 2023\nONDINE BIOMEDICAL INC. \n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\") \nMontreal Heart Institute pilots Steriwave\n· The world-renowned Montreal Heart Institute and Hôpital Fleurimont, University of Sherbrooke (CHUS) in Sherbrooke, Quebec are piloting nasal photodisinfection to prevent post-operative infections in an era of rising antibiotic resistance.\n· 2022 SHEA guidelines elevated nasal decolonization to an essential practice for orthopedic and cardiothoracic surgical procedures.\n· The topical antibiotic commonly used for nasal decolonization has bacterial resistance rates reported as high as 81%.\nTwo of Quebec's leading hospitals, Montreal Heart Institute (MHI), Canada's largest cardiology research centre, and the Hôpital Fleurimont, affiliated with the Centre de Recherche (CHUS), University of Sherbrooke, are piloting Ondine's proprietary Steriwave® nasal photodisinfection in an effort to stay ahead of increasing antibiotic resistance. MHI is evaluating patient outcomes in elective cardiac surgical procedures and Hôpital Fleurimont is evaluating outcomes in elective spine surgeries.\nThe Steriwave nasal photodisinfection treatment, developed by Canadian life sciences company Ondine Biomedical Inc. (LON: OBI), uniquely kills all types of pathogens - viruses, bacteria, and fungi - in minutes without causing resistance. Pre-surgical use of Steriwave in hospital settings has resulted in significant improvement in post-surgical outcomes including lower rates of surgical site infections (SSIs), reduced patient length of stay, fewer readmissions, and lower rates of antibiotic prescribing.[1],[2],[3]\nSurgical site infections (SSIs) are serious complications that can occur following surgery and made worse by the growing resistance to antibiotics. Certain types of infection, such as deep sternal infections, can be a serious threat, increasing a patient's mortality risk by 40% as surgeons have to reopen the sternum to prevent the infection from spreading to internal organs.[4] Cardiac SSIs are strongly associated with poorer prognosis, longer hospitalization, higher medical costs, and high mortality.[5] Post-surgical infections are also a greater risk for spinal surgeries, affecting up to 17% of patients and treatment can be par...